Lilly CEO says weight-loss drug Zepbound weekly prescriptions hit 25,000 in December

The CEO said he expects wide coverage for the drug from pharmacy benefit managers (PBMs) and that at least one major PBM will start recommending coverage of the drug for its clients this year. But he cautioned that employers choosing not to cover weight loss drugs for their health plans would be a constraint on demand.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/GrEp1Pv
via